- Home
- EKSO vs INMB Comparison
EKSO vs INMB Comparison
Compare EKSO & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EKSO | INMB |
|---|---|---|
| Founded | 2005 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 37.2M |
| IPO Year | 2012 | 2018 |
Fundamental Metrics
Financial Performance| Metric | EKSO | INMB |
|---|---|---|
| Price | $11.80 | $1.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $9.50 | $5.40 |
| AVG Volume (30 Days) | 55.1K | ★ 421.4K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.76 | 11.85 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $50,000.00 |
| Revenue This Year | $81.23 | N/A |
| Revenue Next Year | $7.29 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $2.88 | $1.09 |
| 52 Week High | $13.50 | $11.64 |
Technical Indicators
Market Signals| Indicator | EKSO | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 60.17 | 44.79 |
| Support Level | $8.30 | $1.15 |
| Resistance Level | $12.39 | $1.51 |
| Average True Range (ATR) | 0.86 | 0.10 |
| MACD | 0.15 | -0.02 |
| Stochastic Oscillator | 79.44 | 8.33 |
Price Performance
Historical ComparisonAbout EKSO Ekso Bionics Holdings Inc.
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.